Synchronising drug and gene therapies

Cancer can be tackled with a combination of drug and genetic therapies, so that the effectiveness of individual treatments are enhanced.

YANG Yi Yan, Senior Research Fellow, Institute of Materials Research &...
YANG Yi Yan, Senior Research Fellow, Institute of Materials Research & Engineering
That is the result of  a study by Yi-Yan Yang and colleagues at the Institute of Bio-engineering and Nanotechnology in Singapore, published in the October issue of Nature Materials  (http://www.nature.com/naturematerials).
Beyond the promise for a more effective cure, achieving this synergistic effect also means that the dosage of anticancer treatments could be reduced.

The authors used biodegradable nanoparticles made from a polymer that has both a water-loving side and an oil-loving side. When placed in a water solution the polymer spontaneously forms nanoparticles in which the oil-loving part hides in the core, and the water-loving part lines the outside shell. If an oil-loving drug is present in the solution, it will be incorporated in the core. By contrast, the shell can be used to bind DNA or RNA.

The researchers loaded the nanoparticles with a potent anticancer drug and therapeutic gene, injected them in mouse tumours, and observed a significantly slower growth rate in the tumour.

17.11.2006

More on the subject:

Related articles

Photo

Sponsored • On-demand Webinar

Pharmaceutical Press shares the most common types of medication errors

In this on-demand webinar, participants will learn how to safely administer drugs to patients with swallowing difficulties or enteral feeding tubes, including injectable drug compatibility.

Photo

News • Promising trial results from Spain

Clot-dissolving drug after thrombectomy may improve stroke recovery

Even after a blood clot is removed from a large brain artery via thrombectomy, administering the thrombolytic drug alteplase to the area may improve stroke recovery, a new trial from Spain shows.

Photo

News • Study finds faster regain than ending diet programmes

GLP-1 discontinuation: weight-loss drugs work – until you stop

Drawbacks of GLP-1 discontinuation: People tend to regain weight rapidly after stopping weight-loss drugs - and faster than after ending behavioural weight loss programmes - according to new research.

Subscribe to Newsletter